CN102085370B - 一种口腔炎症性疾病的口腔喷剂及其制备方法 - Google Patents
一种口腔炎症性疾病的口腔喷剂及其制备方法 Download PDFInfo
- Publication number
- CN102085370B CN102085370B CN201110031764A CN201110031764A CN102085370B CN 102085370 B CN102085370 B CN 102085370B CN 201110031764 A CN201110031764 A CN 201110031764A CN 201110031764 A CN201110031764 A CN 201110031764A CN 102085370 B CN102085370 B CN 102085370B
- Authority
- CN
- China
- Prior art keywords
- oral
- water
- mouth sprays
- property disease
- oral inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000214 mouth Anatomy 0.000 title abstract description 61
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 208000027866 inflammatory disease Diseases 0.000 title abstract description 4
- 229940041678 oral spray Drugs 0.000 title abstract 5
- 239000000668 oral spray Substances 0.000 title abstract 5
- 206010061218 Inflammation Diseases 0.000 claims abstract description 57
- 230000004054 inflammatory process Effects 0.000 claims abstract description 57
- 229920001661 Chitosan Polymers 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000008215 water for injection Substances 0.000 claims abstract description 23
- 241000241413 Propolis Species 0.000 claims abstract description 19
- 229940069949 propolis Drugs 0.000 claims abstract description 19
- 241000283690 Bos taurus Species 0.000 claims abstract description 16
- 210000003022 colostrum Anatomy 0.000 claims abstract description 15
- 235000021277 colostrum Nutrition 0.000 claims abstract description 15
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 12
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 12
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 12
- 102000016943 Muramidase Human genes 0.000 claims abstract description 12
- 108010014251 Muramidase Proteins 0.000 claims abstract description 12
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 12
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 12
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 12
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 12
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 12
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 12
- 239000004325 lysozyme Substances 0.000 claims abstract description 12
- 229960000274 lysozyme Drugs 0.000 claims abstract description 12
- 230000001954 sterilising effect Effects 0.000 claims abstract description 11
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000007921 spray Substances 0.000 claims description 62
- 201000010099 disease Diseases 0.000 claims description 60
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 60
- 239000000243 solution Substances 0.000 claims description 39
- 102000003992 Peroxidases Human genes 0.000 claims description 11
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 11
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 3
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229960003415 propylparaben Drugs 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 150000004702 methyl esters Chemical class 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims 1
- 201000007100 Pharyngitis Diseases 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 18
- 208000016150 acute pharyngitis Diseases 0.000 abstract description 17
- 230000001154 acute effect Effects 0.000 abstract description 13
- 208000007117 Oral Ulcer Diseases 0.000 abstract description 8
- 208000002399 aphthous stomatitis Diseases 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 7
- 241000700605 Viruses Species 0.000 abstract description 5
- 206010006326 Breath odour Diseases 0.000 abstract description 4
- 208000032139 Halitosis Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 108010023244 Lactoperoxidase Proteins 0.000 abstract 1
- 102000045576 Lactoperoxidases Human genes 0.000 abstract 1
- 230000000675 anti-caries Effects 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 229940057428 lactoperoxidase Drugs 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 12
- 238000005303 weighing Methods 0.000 description 12
- 208000025157 Oral disease Diseases 0.000 description 9
- 208000030194 mouth disease Diseases 0.000 description 9
- 230000028327 secretion Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 208000003265 stomatitis Diseases 0.000 description 7
- 206010044008 tonsillitis Diseases 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 4
- 206010009152 Chronic tonsillitis Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000009442 healing mechanism Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000007800 dental corrosion Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
检测项目 | 检测标准 | 检测结果 | 结论 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
检测项目 | 检测标准 | 检测结果 | 结论 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
检测项目 | 检测标准 | 检测结果 | 结论 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
检测项目 | 检测标准 | 检测结果 | 结论 |
金黄色葡萄球菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
大肠杆菌 | 杀灭率≥99.9% | ≥99.99% | 合格 |
绿脓杆菌 | 杀灭率≥99.9% | ≥99.90% | 合格 |
白色念珠菌 | 杀灭率≥90.0% | ≥99.00% | 合格 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110031764A CN102085370B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔炎症性疾病的口腔喷剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110031764A CN102085370B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔炎症性疾病的口腔喷剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102085370A CN102085370A (zh) | 2011-06-08 |
CN102085370B true CN102085370B (zh) | 2012-09-05 |
Family
ID=44097531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110031764A Expired - Fee Related CN102085370B (zh) | 2011-01-28 | 2011-01-28 | 一种口腔炎症性疾病的口腔喷剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102085370B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105310960A (zh) * | 2015-11-02 | 2016-02-10 | 江苏开源康达医疗器械有限公司 | 一种新型多糖抗菌漱口液及其制备方法 |
EP4017488A4 (en) * | 2019-08-22 | 2024-01-10 | Applied Biological Laboratories, Inc. | COMPOSITIONS AND METHODS USING NON-STEROID ANTI-INFLAMMATORY DRUGS |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824308B (zh) * | 2012-08-31 | 2014-05-28 | 广州润虹医药科技有限公司 | 一种壳聚糖抗菌成膜喷剂及其制备方法 |
CN103690937A (zh) * | 2013-12-02 | 2014-04-02 | 青岛海芬海洋生物科技有限公司 | 一种含海洋生物成分的儿童用龋齿口腔喷剂及其制备方法 |
CN104888202A (zh) * | 2014-05-22 | 2015-09-09 | 闫牧乔 | 一种治疗扁桃体炎的药物 |
CN105796379A (zh) * | 2016-05-06 | 2016-07-27 | 青岛蓝百合生物科技有限公司 | 水溶性壳聚糖口腔护理液及其制备方法 |
CN106075415A (zh) * | 2016-06-30 | 2016-11-09 | 史留喜 | 一种治疗咽喉炎的喷雾剂及其制备方法 |
CN106177923B (zh) * | 2016-07-12 | 2020-08-18 | 方雅悯 | 一种口腔溃疡膜剂及其制备方法 |
CN106938046A (zh) * | 2017-03-16 | 2017-07-11 | 韦毅 | 一种抗菌肽复合酶口腔喷雾剂 |
CN108096429A (zh) * | 2017-12-26 | 2018-06-01 | 庞庆华 | 一种缓解口腔异味的口腔喷剂及其制备方法 |
CN109105708A (zh) * | 2018-05-25 | 2019-01-01 | 徐明灶 | 改善以口腔溃疡为特征上火体质的固体饮料及制备方法 |
CN108578424B (zh) * | 2018-06-09 | 2021-11-05 | 江苏海尔滋生物科技有限公司 | 乙醇多糖长效消毒液及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1342463A (zh) * | 2001-04-05 | 2002-04-03 | 仇壮 | 蜂胶壳聚糖保健药物 |
-
2011
- 2011-01-28 CN CN201110031764A patent/CN102085370B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1342463A (zh) * | 2001-04-05 | 2002-04-03 | 仇壮 | 蜂胶壳聚糖保健药物 |
Non-Patent Citations (1)
Title |
---|
李治等.O-羧甲基壳聚糖抗菌性的研究.《日用化学工业》.2000,(第3期),第10、11页. * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105310960A (zh) * | 2015-11-02 | 2016-02-10 | 江苏开源康达医疗器械有限公司 | 一种新型多糖抗菌漱口液及其制备方法 |
CN105310960B (zh) * | 2015-11-02 | 2018-03-30 | 江苏开源康达医疗器械有限公司 | 一种新型多糖抗菌漱口液及其制备方法 |
EP4017488A4 (en) * | 2019-08-22 | 2024-01-10 | Applied Biological Laboratories, Inc. | COMPOSITIONS AND METHODS USING NON-STEROID ANTI-INFLAMMATORY DRUGS |
Also Published As
Publication number | Publication date |
---|---|
CN102085370A (zh) | 2011-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102085370B (zh) | 一种口腔炎症性疾病的口腔喷剂及其制备方法 | |
CN106334067B (zh) | 含银离子抗菌剂的妇科凝胶、制备方法及应用 | |
EP2775838B1 (en) | Aqueous antimicrobial composition containing coniferous resin acids | |
US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
KR20090129490A (ko) | 호로파 추출물 | |
CN102028705A (zh) | 一种含生物抑菌成分的妇科用品 | |
KR20190126302A (ko) | 키토산-함유 제제 및 그의 제조 및 사용 방법 | |
CN101953860A (zh) | 一种缓解痔疮症状的湿巾及其生产方法 | |
EP0424534A1 (en) | Pharmaceutical preparation for treatment of mastitis in animals and humans | |
WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
CN111568919A (zh) | 一种含壳寡糖的抗幽门螺旋杆菌制剂 | |
CN114028546A (zh) | 复合多肽杀菌制剂及其制备方法和用途 | |
EP3190893A1 (en) | Compositions and methods for treating and preventing bacterial infections | |
CN102085369B (zh) | 一种口腔干燥症凝胶医疗用品及其制备方法 | |
CN102085371B (zh) | 一种口腔干燥症含漱液医疗用品及其制备方法 | |
AU2011296641B2 (en) | Antifungal composition | |
US12083167B2 (en) | Ovotransferrin treatment for the reproductive tract | |
CN101744926B (zh) | 一种中药抗菌洗液及其制备方法 | |
CN111407789A (zh) | 一种泡沫型日常预防治动物蹄浴液及其制备方法与应用 | |
CN116236439A (zh) | 一种胶态银抑菌凝胶及其制备方法和应用 | |
CN105412913A (zh) | 一种鼻腔润湿剂 | |
CN111632073A (zh) | 一种抗菌消炎的女性私密益生菌组合物及其制备 | |
CN105030813B (zh) | 一种用于治疗羊口炎的复方制剂 | |
CN105055713A (zh) | 一种预防或治疗褥疮的药物组合物及其制备方法 | |
CN111214409A (zh) | 一种免洗消毒液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to an oral spray for oral inflammatory diseases and a preparation method thereof Effective date of registration: 20211216 Granted publication date: 20120905 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230403 Granted publication date: 20120905 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Wuhan Coupling Medicine Technology Co.,Ltd. Registration number: Y2021420000144 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 |